Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 13, 2021

Previous Nivolumab Treatment Improves the Response to Taxanes in Patients With Recurrent/Metastatic HNSCC

European Journal of Cancer


Additional Info

European Journal of Cancer
Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
Eur. J. Cancer 2021 Dec 01;159(xx)125-132, E Guiard, F Clatot, C Even, M Perréard, C Abdeddaim, A Johnson, E Vauléon, A Rambeau

Further Reading